News
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults ...
GSK sponsors the 2025 National Senior Games to raise awareness about RSV risks and prevention for older adults through education and athlete stories.
GSK is taking to the airwaves to get the message out about respiratory syncytial virus (RSV), presenting a TV special about how the pathogen has affected athletes in the upcoming National Senior Games ...
4d
MyChesCo on MSNGSK Highlights RSV Awareness Through National Senior Games Partnership and New TV SpecialGSK plc has announced its sponsorship of the 2025 National Senior Games as part of its Sideline RSV campaign, a nationwide health education initiative aimed at informing adults ...
(Reuters) -British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults ...
London: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted for review an application to extend the indication of Arexvy (respiratory syncytial virus (RSV) ...
3d
GlobalData on MSNGSK’s speciality medicines soar while generals drop, Q2 results revealUK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...
10d
Verywell Health on MSNThe Best Time to Get an RSV Vaccine for Older AdultsThe CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...
GSK announces US FDA accepts application to review expanded use of RSV vaccine, Arexvy for adults 18-49 at increased risk: London, UK Wednesday, July 16, 2025, 14:00 Hrs [IST] GSK ...
Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...
July is Chronic Disease Awareness Month and serves as an important reminder to take charge of your health and get informed ...
Drugmaker GSK said on Wednesday that Q2 revenues had grown as a strong specialty medicines performance drove sales and core ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results